Article
Diagnosis and treatment of therapy-related acute myeloid leukemia.
Critical reviews in oncology/hematology - 1 Mar 2022
Strickland Stephen A, Vey Norbert
Abstract excerpt
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, accounts for 7 %-8 % of AML cases and primarily occurs in elderly patients. t-AML is associated with an increased probability of adverse cytogenetics and shortened survival compared with de novo AML. Factors predicting poorer prognosis in t-AML include...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
